secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2022-05-04T23:59:59+00:00
Accession:  0000950170-22-007143
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical closes $54M draw on $150M MidCap debt facility; refinances $30M CRG loan
--------------------------------------------------------------------------------

- $150M total facility ($120M term + $30M revolver) with MidCap; $54M drawn at closing.
- Proceeds used to refinance existing $30M CRG term loan and replace $10M SVB revolver.
- Interest: Adjusted Term SOFR (floor 1%, cap 3%) + 6% (term) or 4% (revolver); 48-month interest-only.
- Liquidity now ~$220M including undrawn revolver; no min revenue covenant if liquidity > outstanding term loan.
- CEO John Treace says financing provides capital-efficient vehicle to invest in growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022007143/0000950170-22-007143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022007143/tmci-20220429.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-007143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer